Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
Serum Institute of India Pvt. Ltd., a biotechnology company that develops and manufactures vaccines for diphtheria, tetanus, pertussis, Hib, BCG, r-hepatitis B, measles, mumps, and rubella disease.
Serum Institute Of India Private Limited, is an unlisted private company incorporated on 22 May, 1984. It is classified as a private limited company and is located in Pune, Maharashtra. It's authorized share capital is INR 55.00 cr and the total paid-up capital is INR 4.82 cr.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR crores. Based on March 2024 numbers.
-6.29%
-19.79%
2.17%
11.61%
429.82%
11.5%
-1.62
-7.96
-0.39
-0.96
-15.53
0.01
Buy Report or Plans
Company dashboard
Five year financials and ratios
Risk analysis
Interactive charts
All financials
All annual returns
MoA and AoA
Latest financials
Latest annual return
MoA and AoA
Five year financials and ratios
Shareholding and group structure
Litigation and more
Everything in financial report
Peers and financials
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(13)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||||
| Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Performance | |||||
| Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return + | |||||
| Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||||
| Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital | |||||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
AMBIT CAPITAL PRIVATE LIMITED
No. of Loans: 1
Total Amount : 10.0 cr
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Managing Director | Cyrus Soli Poonawalla
Shareholder
|
00044650 | 17 years |
| Director | Zavareh Soli Poonawalla
Shareholder
|
00044760 | 41 years |
| Whole-time Director | Adar Cyrus Poonawalla
Shareholder
|
00044815 | 17 years |
| Kmp | Adar Cyrus Poonawalla | <HIDDEN> | 10 years |
| Director | Behroze Zavareh Poonawalla | 00044877 | 39 years |
| Whole-time Director | Umesh Sharadrao Shaligram | 00212458 | 4 years |
| Whole-time Director | Satish Ramchandra Mundra | 00416654 | 15 years |
| Whole-time Director | Natasha Adar Poonawalla | 01264082 | 8 years |
| Kmp | Sunder Lata Anand Kavitkar | <HIDDEN> | 2 years |
| Director | Parag Rajendra Deshmukh | 03377341 | 1 years |
| Whole-time Director | Kedar Shashikant Gokhale | 08788551 | 3 years |
| Whole-time Director | Sunil Gairola | 08893242 | 4 years |
| Whole-time Director | Prasad Suryakant Kulkarni | 08991838 | 4 years |
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| SOVEREIGN PHARMA PRIVATE LIMITED |
Active
|
98.0 Cr | 2 | Maharashtra |
| ADRUS ESTATES AND PROPERTIES PVT LTD |
Converted to LLP and Dissolved
|
1.0 L | 1 | Maharashtra |
| VILLOO POONAWALLA RACING & BREEDING PRIVATE LIMITED |
Active
|
44.0 Cr | 3 | Maharashtra |
| GENESIS PARKS LLP |
Active
|
5.0 Cr | 2 | Maharashtra |
| ADAR ESTATES LLP |
Active
|
5.0 Cr | 2 | Maharashtra |
| POONAWALLA AVIATION PRIVATE LIMITED |
Active
|
1,410.3 Cr | 1 | Maharashtra |
| POONAWALLA INVESTMENTS AND INDUSTRIES PRIVATE LIMITED |
Active
|
98.6 L | 2 | Maharashtra |
| POONAWALLA ESTATES STUD AND AGRI FARM PRIVAE LIMITED |
Active
|
41.4 Cr | 2 | Maharashtra |
| SERUM INTERNATIONAL LIMITED |
Amalgamated
|
4.1 Cr | 4 | Maharashtra |
| THE POONA STUD FARM PRIVATE LIMITED |
Active
|
1.6 Cr | 2 | Maharashtra |
| POONAWALLA ASTONISH STUD PRIVATE LIMITED |
Active
|
5.6 Cr | 2 | Maharashtra |
| ASTONISH STUD PRIVATE LIMITED |
Amalgamated
|
24.3 L | 2 | Maharashtra |
| SHELLAC TRADING PRIVATE LIMITED |
Strike Off
|
1,000.0 | 1 | Maharashtra |
| ANNILNA INVESTMENT PVT LTD |
Active
|
28.0 L | 2 | Maharashtra |
| SIMONE POONAWALLA CONSTRUCTIONS AND STUD PRIVATE LIMITED |
Active
|
20.3 L | 1 | Maharashtra |
| INTERVALVE POONAWALLA LIMITED |
Active
|
8.8 Cr | 1 | Maharashtra |
| YODELSIM HOLDINGS PVT. LTD. |
Active
|
88.5 L | 2 | Maharashtra |
| SASWAD INVESTMENT PVT LTD |
Amalgamated
|
99.8 L | 1 | Maharashtra |
| POONAWALLA FINVEST AND AGRO PRIVATE LIMITED |
Active
|
87.0 L | 2 | Maharashtra |
| POONAWALLA FINANCIALS PRIVATE LIMITED |
Active
|
20.9 Cr | 2 | Maharashtra |
| EL-O-MATIC (INDIA) PRIVATE LIMITED |
Active
|
96.8 L | 1 | Maharashtra |
| CARTIER INVESTMENT PRIVATE LIMITED |
Active
|
3.5 Cr | 1 | Maharashtra |
| DELNA PROPERTIES PRIVATE LIMITED |
Converted to LLP and Dissolved
|
1.0 L | 2 | Maharashtra |
| POONAWALLA RACING AND BREEDING PRIVATE LIMITED |
Active
|
10.0 L | 2 | Maharashtra |
| POONAWALLA HOTELS PRIVATE LIMITED |
Converted to LLP and Dissolved
|
1.0 L | 1 | Maharashtra |
| YOHAN POONAWALLA FINANCIALS PRIVATE LIMI TED |
Amalgamated
|
1.1 Cr | 2 | Maharashtra |
| POONAWALLA EXHILARATION STUD PRIVATE LIMITED |
Active
|
5.0 L | 2 | Maharashtra |
| POONAWALLA MYSTICAL STUD PRIVATE LIMITED |
Active
|
5.0 L | 2 | Maharashtra |
| POONAWALLA CONSTRUCTIONS PRIVATE LIMITED |
Converted to LLP and Dissolved
|
18.4 Cr | 1 | Maharashtra |
| EXHILARATION STUD PRIVATE LIMITED |
Converted to LLP and Dissolved
|
1.0 L | 2 | Maharashtra |
| POONAWALLA REAL ESTATES AND HOTELS LLP |
Active
|
18.6 Cr | 1 | Maharashtra |
| SIMONE POONAWALLA PROJECTS LLP |
Active
|
10.0 L | 2 | Maharashtra |
| DELNA POONAWALLA PROJECTS LLP |
Active
|
10.0 L | 2 | Maharashtra |
| DELNA PROPERTIES LLP |
Active
|
1.0 L | 2 | Maharashtra |
| CYZA AGRO AND STUD FARMS LLP |
Active
|
24.9 L | 1 | Maharashtra |
| POONAWALLA CONSTRUCTIONS LLP |
Active
|
18.4 Cr | 2 | Maharashtra |
| CARTIER PROPERTIES LLP |
Active
|
3.5 Cr | 1 | Maharashtra |
| POONAWALLA HOLDINGS LLP |
Active
|
1.4 Cr | 2 | Maharashtra |
| SHELLAC PROPERTIES LLP |
Active
|
95.5 L | 1 | Maharashtra |
| YOHAN POONAWALLA PROJECTS LLP |
Active
|
10.0 L | 2 | Maharashtra |
| POONAWALLA STUD FARM PRIVATE LIMITED |
Active
|
5.4 L | 1 | Maharashtra |
| CYZA AGRO AND STUD FARMS PRIVATE LIMITED |
Converted to LLP and Dissolved
|
24.9 L | 2 | Maharashtra |
| SANOTI PROPERTIES LLP |
Active
|
10.0 Cr | 1 | Maharashtra |
| SERUM INSTITUTE LIFE SCIENCES PRIVATE LIMITED |
Active
|
636.6 Cr | 6 | Maharashtra |
| RISING SUN HOLDINGS PVT LTD |
Active
|
7,794.0 Cr | 1 | Maharashtra |
| POONAWALLA FINCORP LIMITED |
Active
|
155.5 Cr | 1 | Maharashtra |
| POONAWALLA FINANCE PRIVATE LIMITED |
Active
|
1,230.6 Cr | 1 | Maharashtra |
| POONAWALLA CREDIT PRIVATE LIMITED |
Active
|
254.9 Cr | 1 | Maharashtra |
| COVIDSHIELD TECHNOLOGIES PRIVATE LIMITED |
Active
|
7.5 Cr | 1 | Maharashtra |
| AMRON REALTORS PRIVATE LIMITED |
Active
|
107.5 Cr | 1 | Maharashtra |
| SRI THAKUR BIOTECH LLP |
Active
|
50,000.0 | 1 | Maharashtra |
| PHINITY DEVELOPERS PRIVATE LIMITED |
Active
|
1,061.0 Cr | 1 | Maharashtra |
| KEDAR GOKHALE ADVISORY LLP |
Active
|
5,000.0 | 1 | Maharashtra |
| GAIROLA BIOTECH ADVISORY LLP |
Active
|
1.0 L | 1 | Maharashtra |
| PAURAS ADVISORY LLP |
Active
|
50,000.0 | 1 | Maharashtra |
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| SERUM INTERNATIONAL B.V. | Netherlands | - | - |
| Bilthoven Biologicals B.V. | Netherlands | - | - |
| SERUM INSTITUTE INC | United States | - | - |
| Serum Life Science Europe Gmbh | Germany | - | - |
| SEZ BIOTECH SERVICES PRIVATE LIMITED | Maharashtra | 2006 | ₹ 1,250.4 Cr |
| POONAWALLA AVIATION PRIVATE LIMITED | Maharashtra | 2005 | ₹ 1,410.3 Cr |
| Serum Life Sciences B.V | Netherlands | - | - |
| Serum AMR Products B.V. | Netherlands | - | - |
| SERUM INSTITUTE LIFE SCIENCES PRIVATE LIMITED | Maharashtra | 2020 | ₹ 636.6 Cr |
| Serum Life Sciences Ltd | United Kingdom | - | - |
| COVIDSHIELD TECHNOLOGIES PRIVATE LIMITED | Maharashtra | 2019 | ₹ 7.5 Cr |
| SERUM INSTITUTE VACCINES PRIVATE LIMITED | Maharashtra | 2021 | ₹ 113.3 Cr |
| SERUM LIFECARE FOUNDATION | Maharashtra | 2023 | ₹ 0.0 |
| Serum Global FZCO | United Arab Emirates | - | - |
| Serum Middle East Holdings FZCO | United Arab Emirates | - | - |
| Diamond Worldwide Finance Ltd | United Kingdom | - | - |
The incorporation date of SERUM INSTITUTE OF INDIA PRIVATE LIMITED is 22 May, 1984
The authorized share capital of SERUM INSTITUTE OF INDIA PRIVATE LIMITED is INR ₹ 55.0 Cr.
The paid-up capital of SERUM INSTITUTE OF INDIA PRIVATE LIMITED is INR ₹ 4.8 Cr.
The registered address of SERUM INSTITUTE OF INDIA PRIVATE LIMITED is 212/2 OFF SOLI POONAWALLA ROAD, HADAPSAR PUNE Pune Maharashtra - 411028
The CIN number of SERUM INSTITUTE OF INDIA PRIVATE LIMITED is U80903PN1984PTC032945.
Expand
Delete
Collapse
See
details
